Algal Biotechnology
Algal biotechnology could also be a technology developed using algae . Biotechnology is to more the understanding of the ecology of microalgae. this will assist with the event of commercial-scale small protoctist culturing techniques for the assembly of bioactive compounds, cultivation feed, fine chemicals, and renewable fuels. additionally , environmental applications like CO2 bioremediation, management of excessive protoctist growth and development of management ways for installation managers area unit investigated. Trangenesis in protoctist could also be a advanced and invasive technology. Selectable marker genes, promoters, communicator genes, transformation techniques, and different genetic tools and ways area unit already accessible for varied species and presently ~25 species area unit accessible to genetic transformation. Fortuitously, large-scale sequencing comes are also planned, ongoing, or completed for several of these species. A $2.4M order for Algae.Tec algae production technology as a follow-up to an initial investment of A$1.5M by Reliance, with additional investments of AU$1.2 million over subsequent 2 years.
- Microbial biotechnology
- Plant nutrition
Related Conference of Algal Biotechnology
20th World Congress on Biomarkers, Cancer Therapy & Clinical Research
7th Annual Congress on Biosimilars and Future Biotherapeutics
41st International Conference on Next-Gen Biotechnology and Applications
Algal Biotechnology Conference Speakers
Recommended Sessions
- Algal Biotechnology
- Animal Biotechnology
- Bio Economy
- Biomass and Bioenergy
- Biotechnology
- Biotechnology and Bioprocess Engineering
- Biotechnology Applications
- Biotechnology Enterprise and Entrepreneurship
- Biotechnology Products
- Cell/Molecular Biotechnology
- Environmental Biotechnology
- Food Biotechnology
- Genetic Engineering
- Marine Biotechnology
- Medical Biotechnology
- Nano Biotechnology
- Pharmaceutical Biotechnology
- Plant and Agriculture Biotechnology
- Stem Cell Biotechnology
- Systems and Synthetic Biotechnology
Related Journals
Are you interested in
- 3D Bioprinting & Regenerative Medicine - Biotechnology- 2025 (France)
- Advancements in Analytical Techniques - ANALYTICA ACTA 2025 (France)
- Advancements in Biosimilar Development Technologies - Biosimilars 2026 (France)
- Advances in Genomic Biotechnology - Biotechnology 2025 (Spain)
- AI in Drug Discovery - Biotechnology- 2025 (France)
- AI in Vaccine Development - Biotechnology- 2025 (France)
- AI-Powered Precision Medicine - Biotechnology- 2025 (France)
- Analytical Challenges in Personalized Medicine - ANALYTICA ACTA 2025 (France)
- Analytical Chemistry in Agriculture - ANALYTICA ACTA 2025 (France)
- Analytical Chemistry in the Energy Sector - ANALYTICA ACTA 2025 (France)
- Analytical Techniques for Biotechnology - ANALYTICA ACTA 2025 (France)
- Analytical Techniques in Material Science - ANALYTICA ACTA 2025 (France)
- Artificial Intelligence and Digital Tools in Biotherapeutics - Biosimilars 2026 (France)
- Automation in Bioanalytical Laboratories - ANALYTICA ACTA 2025 (France)
- Bio-Cybernetics & Smart Implants - Biotechnology- 2025 (France)
- Bioanalytical Method Development and Validation - ANALYTICA ACTA 2025 (France)
- Biobetters: The Next Generation of Biologics - Biosimilars 2026 (France)
- Bioethics in Biotechnology 5.0 - Biotechnology- 2025 (France)
- Bioinformatics & Big Data - Biotechnology- 2025 (France)
- Bioinformatics and Computational Approaches - ANALYTICA ACTA 2025 (France)
- Biomedical Biotechnology - Biotechnology 2025 (Spain)
- Biopharmaceuticals and Biologics - ANALYTICA ACTA 2025 (France)
- Biopharmaceuticals and Biosimilars - Biotechnology 2025 (Spain)
- Biosimilar Market Access and Reimbursement Policies - Biosimilars 2026 (France)
- Biosimilars in Oncology and Autoimmune Diseases - Biosimilars 2026 (France)
- Biosimilars in Rare and Orphan Diseases - Biosimilars 2026 (France)
- Biotechnology and Global Health - Biotechnology 2025 (Spain)
- Biotechnology in Agriculture - Biotechnology 2025 (Spain)
- Biotechnology in Space - Biotechnology- 2025 (France)
- Blockchain for Biotech Data Security - Biotechnology- 2025 (France)
- Brain-Computer Interfaces & Neurobiotech - Biotechnology- 2025 (France)
- Chemical Analysis and Sensing - ANALYTICA ACTA 2025 (France)
- Clinical and Forensic Analysis - ANALYTICA ACTA 2025 (France)
- Clinical Trials & Comparability Studies for Biosimilars - Biosimilars 2026 (France)
- Collaborative Models in Biosimilar Development - Biosimilars 2026 (France)
- Computational and Systems Biology - Biotechnology 2025 (Spain)
- Cost-Effectiveness and Health Economics of Biosimilars - Biosimilars 2026 (France)
- CRISPR & Beyond - Biotechnology- 2025 (France)
- Data Integrity and Compliance in Analytical Chemistry - ANALYTICA ACTA 2025 (France)
- Emerging Contaminants and Analytical Challenges - ANALYTICA ACTA 2025 (France)
- Emerging Trends in Analytical and Bioanalytical Techniques - ANALYTICA ACTA 2025 (France)
- Environmental Analysis - ANALYTICA ACTA 2025 (France)
- Environmental Biotechnology - Biotechnology 2025 (Spain)
- Evolving Trends and Innovations in Biosimilar Development and Access - Biosimilars 2026 (France)
- Food and Beverage Analysis - ANALYTICA ACTA 2025 (France)
- Formulation and Delivery Systems for Biologics - Biosimilars 2026 (France)
- Future Biotherapeutics: Cell and Gene Therapies - Biosimilars 2026 (France)
- Future of AgriTech - Biotechnology- 2025 (France)
- Future of Monoclonal Antibodies and Fusion Proteins - Biosimilars 2026 (France)
- Future Trends in Biotechnology - Biotechnology 2025 (Spain)
- Genomics and Molecular Biology Analysis - ANALYTICA ACTA 2025 (France)
- Global Trends and Challenges in Biosimilar Adoption - Biosimilars 2026 (France)
- High-Resolution Techniques - ANALYTICA ACTA 2025 (France)
- Imaging Techniques and Microscopy - ANALYTICA ACTA 2025 (France)
- Immunogenicity Assessment and Risk Management - Biosimilars 2026 (France)
- Industrial Biotech & Smart Biofactories - Biotechnology- 2025 (France)
- Industrial Biotechnology - Biotechnology 2025 (Spain)
- Industrial Scale-Up and Bioprocessing - Biotechnology 2025 (Spain)
- Instrumentation and Automation in Analytical Chemistry - ANALYTICA ACTA 2025 (France)
- Interchangeability and Substitution Policies - Biosimilars 2026 (France)
- Manufacturing and Quality Control of Biosimilars - Biosimilars 2026 (France)
- Marine Biotechnology - Biotechnology 2025 (Spain)
- Metabolomics and Proteomics - ANALYTICA ACTA 2025 (France)
- Microbial Biotechnology - Biotechnology 2025 (Spain)
- Nanomaterials and Nanotechnology in Analysis - ANALYTICA ACTA 2025 (France)
- Nanotechnology in Medicine - Biotechnology- 2025 (France)
- Patient and Physician Perspectives on Biosimilar Use - Biosimilars 2026 (France)
- Personalized Nutrition & Gut Microbiome - Biotechnology- 2025 (France)
- Pharmaceutical Analysis - ANALYTICA ACTA 2025 (France)
- Pharmacovigilance and Post-Marketing Surveillance - Biosimilars 2026 (France)
- Quality by Design (QbD) in Analytical Method Development - ANALYTICA ACTA 2025 (France)
- Quantum Computing in Biotech - Biotechnology- 2025 (France)
- Regenerative Medicine and Analytical Techniques - ANALYTICA ACTA 2025 (France)
- Regulatory Pathways and Global Harmonization - Biosimilars 2026 (France)
- Smart Biomanufacturing - Biotechnology- 2025 (France)
- Spectroscopic Techniques - ANALYTICA ACTA 2025 (France)
- Stem Cell and Regenerative Medicine - Biotechnology 2025 (Spain)
- Surface and Interface Analysis - ANALYTICA ACTA 2025 (France)
- Sustainable Biotech Innovations - Biotechnology- 2025 (France)
- Synthetic Biology and Bioengineering - Biotechnology 2025 (Spain)
- Synthetic Biology: Reprogramming Life - Biotechnology- 2025 (France)
- The Future of Biotech Startups - Biotechnology- 2025 (France)
- Vaccine Development and Immunotherapy - Biotechnology 2025 (Spain)
- Workshops and Hands-On Training - ANALYTICA ACTA 2025 (France)